US Bancorp’s Virtus LifeSci Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.3K | Hold |
1,000
| – | – | ﹤0.01% | 3174 |
|
|
2025
Q1 | $17.5K | Hold |
1,000
| – | – | ﹤0.01% | 3219 |
|
|
2024
Q4 | $23.9K | Hold |
1,000
| – | – | ﹤0.01% | 3083 |
|
|
2024
Q3 | $27.9K | Hold |
1,000
| – | – | ﹤0.01% | 2997 |
|
|
2024
Q2 | $25.3K | Hold |
1,000
| – | – | ﹤0.01% | 2961 |
|
|
2024
Q1 | $29.1K | Hold |
1,000
| – | – | ﹤0.01% | 2935 |
|
|
2023
Q4 | $24.5K | Hold |
1,000
| – | – | ﹤0.01% | 2965 |
|
|
2023
Q3 | $19.6K | Hold |
1,000
| – | – | ﹤0.01% | 2884 |
|
|
2023
Q2 | $24K | Hold |
1,000
| – | – | ﹤0.01% | 2863 |
|
|
2023
Q1 | $21.9K | Hold |
1,000
| – | – | ﹤0.01% | 2936 |
|
|
2022
Q4 | $25K | Hold |
1,000
| – | – | ﹤0.01% | 2868 |
|
|
2022
Q3 | $25K | Hold |
1,000
| – | – | ﹤0.01% | 2901 |
|
|
2022
Q2 | $22K | Hold |
1,000
| – | – | ﹤0.01% | 2980 |
|
|
2022
Q1 | $28K | Hold |
1,000
| – | – | ﹤0.01% | 2880 |
|
|
2021
Q4 | $39K | Hold |
1,000
| – | – | ﹤0.01% | 2762 |
|
|
2021
Q3 | $45K | Hold |
1,000
| – | – | ﹤0.01% | 2694 |
|
|
2021
Q2 | $50K | Hold |
1,000
| – | – | ﹤0.01% | 2662 |
|
|
2021
Q1 | $51K | Hold |
1,000
| – | – | ﹤0.01% | 2565 |
|
|
2020
Q4 | $50K | Hold |
1,000
| – | – | ﹤0.01% | 2501 |
|
|
2020
Q3 | $39K | Hold |
1,000
| – | – | ﹤0.01% | 2489 |
|
|
2020
Q2 | $43K | Hold |
1,000
| – | – | ﹤0.01% | 2442 |
|
|
2020
Q1 | $29K | Hold |
1,000
| – | – | ﹤0.01% | 2529 |
|
|
2019
Q4 | $39K | Buy |
+1,000
| New | +$39K | ﹤0.01% | 2572 |
|